126 related articles for article (PubMed ID: 25622680)
21. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
[TBL] [Abstract][Full Text] [Related]
23. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
24. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.
Sandoval R; Xue J; Pilkinton M; Salvi D; Kiyokawa H; Colamonici OR
J Biol Chem; 2004 Jul; 279(31):32275-80. PubMed ID: 15169789
[TBL] [Abstract][Full Text] [Related]
25. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
26. Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2.
Alshatwi AA; Subash-Babu P; Antonisamy P
Exp Toxicol Pathol; 2016 Jan; 68(1):89-97. PubMed ID: 26521020
[TBL] [Abstract][Full Text] [Related]
27. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
Li QC; Xu H; Wang X; Wang T; Wu J
Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
[TBL] [Abstract][Full Text] [Related]
28. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
[TBL] [Abstract][Full Text] [Related]
29. JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis.
Zheng CJ; Yang LL; Liu J; Zhong L
J Recept Signal Transduct Res; 2018 Apr; 38(2):133-140. PubMed ID: 29447541
[TBL] [Abstract][Full Text] [Related]
30. p53 siRNA inhibits apoptosis of U2OS cells treated with azurin.
Yan X; Feng J; Ye Z; Miao X; Li W; Yang D
Mol Med Rep; 2011; 4(6):1089-94. PubMed ID: 21822538
[TBL] [Abstract][Full Text] [Related]
31. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
Zhu JJ; Li FB; Zhu XF; Liao WM
Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212
[TBL] [Abstract][Full Text] [Related]
32. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
[TBL] [Abstract][Full Text] [Related]
33. BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.
Basma H; El-Refaey H; Sgagias MK; Cowan KH; Luo X; Cheng PW
J Biomed Sci; 2005 Dec; 12(6):999-1011. PubMed ID: 16228292
[TBL] [Abstract][Full Text] [Related]
34. Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells.
Yang DS; Miao XD; Ye ZM; Feng J; Xu RZ; Huang X; Ge FF
Pharmacol Res; 2005 Nov; 52(5):413-21. PubMed ID: 16026999
[TBL] [Abstract][Full Text] [Related]
35. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
Raffo AJ; Kim AL; Fine RL
Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
[TBL] [Abstract][Full Text] [Related]
36. Apoptotic effects of curcumin on human osteosarcoma U2OS cells.
Jin S; Xu HG; Shen JN; Chen XW; Wang H; Zhou JG
Orthop Surg; 2009 May; 1(2):144-52. PubMed ID: 22009832
[TBL] [Abstract][Full Text] [Related]
37. DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells.
Chen JT; Fong YC; Li TM; Liu JF; Hsu CW; Chang CS; Tang CH
Eur J Pharmacol; 2008 Nov; 597(1-3):19-26. PubMed ID: 18822283
[TBL] [Abstract][Full Text] [Related]
38. The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells.
Zhu JJ; Li FB; Zhou JM; Liu ZC; Zhu XF; Liao WM
Cancer Biol Ther; 2005 Jan; 4(1):39-47. PubMed ID: 15662138
[TBL] [Abstract][Full Text] [Related]
39. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
[TBL] [Abstract][Full Text] [Related]
40. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
